Progenitor Cell Differentiation for Insulin Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The shortage of functional insulin-producing pancreatic cells for diabetes treatment, particularly due to the limited supply of human pancreatic cells, necessitates a method to differentiate progenitor cells from non-pancreatic tissues into insulin-producing pancreatic cells.
Innovation Solution
A method involving the incubation of progenitor cells in serum-free pre-induction media with sodium butyrate followed by induction media with knock-out replacement serum to differentiate them into insulin-producing pancreatic cells, using hepatic, umbilical cord matrix, or adipose stem cells, which can then be used for cell therapy or drug screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If donor pancreatic cells are used to treat diabetes, then insulin production is improved, but the supply of cells is insufficient
Solution Approach 1:
The patent creates functional copies of pancreatic beta cells by differentiating progenitor cells (from adipose, hepatic, or umbilical cord tissues) into insulin-producing cells. These copied cells replicate the essential function of donor pancreatic cells without requiring actual donor tissue, thereby solving the scarcity problem while maintaining therapeutic reliability
Solution Approach 2:
The patent employs specific media compositions with defined parameters (serum-free conditions, sodium butyrate at 2mmol/L, knock-out replacement serum at 2%) to control and optimize the differentiation process. By precisely controlling these media parameters, the method achieves reliable conversion of progenitor cells into functional insulin-producing cells with consistent quality
2Quantity of substance
If progenitor cells from non-pancreatic tissue are differentiated into insulin-producing cells, then the supply of insulin-producing cells is increased, but the differentiation process becomes more complex
Solution Approach 1:
The differentiation protocol is segmented into distinct temporal phases: pre-induction phase (2 days in serum-free media with sodium butyrate), induction phase (transition to knock-out replacement serum), and maturation phase. This segmentation allows each phase to be optimized independently, managing overall complexity through structured progression
Solution Approach 2:
The patent establishes a universal differentiation protocol that can convert multiple types of progenitor cells (adipose stem cells, hepatic stem cells, umbilical cord matrix cells) into insulin-producing cells using the same media strategy. This multi-functional approach simplifies the overall system by creating a single protocol that handles diverse cell sources
3Reliability
If cell-based therapy is used to replenish lost pancreatic cells, then diabetes treatment is improved, but the quality of donor cells deteriorates
Solution Approach 1:
The method enables patients to receive quality-controlled cells through autologous transplantation, where their own progenitor cells (from adipose, hepatic, or umbilical cord tissues) are differentiated into insulin-producing cells and retransplanted. This self-service approach eliminates the quality variability inherent in allogeneic donor cells while maintaining therapeutic effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively increases the supply of insulin-producing pancreatic cells, enabling their use in treating diabetes and evaluating compound toxicity and activity, while also providing a drug screening kit for assessing insulin production and gene expression.
Implementation Method 1
incubating the progenitor cells in serum-free pre-induction media comprising 2 mmol/L sodium butyrate; and, subsequently, (b) incubating the progenitor cell in induction media comprising knock-out replacement serum
Data Source
AI summary
The invention relates to methods for differentiating progenitor cells into insulin producing pancreatic islet cells and compositions and methods for using such cells.